Abemaciclib for Treatment of Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration
Conditions: Chondrosarcoma; Osteosarcoma; Soft Tissue Sarcoma Intervention: Drug: Abemaciclib Sponsor: Medical College of Wisconsin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials